William B. III Stilley

CIK 1718069 · Chief Executive Officer · last filed 2023-05-25

William B. III Stilley is a Chief Executive Officer who has filed 15 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for ADILW, was dated May 25, 2023. Across all open-market trades the lifetime net is +$87.6K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

15

Lifetime Open-Market Net

$87.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Chief Executive Officer 1,393,920 $0.00 $1.3K $87.6K 12 2023-05-25
ALBT Director $0.33 $0 1 2023-03-08
Avalon GloboCare Corp. (AVCO) Delisted Director $0.53 $0 1 2020-02-25

Recent Filings

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-25 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Grant (A) +240,800 $0 EDGAR
2023-03-08 ALBT Grant (A) $0 EDGAR
2023-01-03 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Disp (D) −166,667 $0 EDGAR
2022-08-23 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Grant (A) $0 EDGAR
2022-02-25 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Grant (A) +250,000 $0 EDGAR
2021-12-01 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Buy (P) +20,600 $55.1K EDGAR
2021-09-10 Grant (A) +50,000 $0
2021-02-10 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Grant (A) $0 EDGAR
2021-01-28 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Grant (A) +201,109 $0 EDGAR
2020-03-27 ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted Buy (P) +25,000 $32.6K EDGAR
Showing 110 of 15
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.